Invitation to teleconference for analysts, investors and journalists

Presentation of Meda’s Second Quarter Results 2014

On Wednesday, August 13th, 2014 at 8:00 CET, Meda will release its second quarter results for 2014. Meda invites all analysts, investors and media to a teleconference to be held on Wednesday, August 13th at 10:30 CET.

During the teleconference, CEO Jörg-Thomas Dierks and CFO Henrik Stenqvist will present the 2014 second quarter report.

The second quarter report will be available at Meda’s website, Slides from the presentation will be available at the same address. The webcast presentation can be heard at:

To participate in the telephone conference, please call:

SE: +46 8 505 564 74
UK: +44 203 364 5374
US: +1 855 753 2230

For further information, please contact

Paula Treutiger, +46 8 630 2082

MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 120 countries worldwide and the company is represented by its own organizations in close to 60 countries. The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. Find out more, visit



About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.


Documents & Links